Cargando…
Venous thromboembolism: current management
Anticoagulation is indicated in most cases of venous thromboembolism Monotherapy with rivaroxaban or apixaban is the preferred option for most adults with acute venous thromboembolism There are no recommended dose reductions for rivaroxaban or apixaban in venous thromboembolism, unlike for atrial fi...
Autores principales: | Stevens, Hannah, Tran, Huyen, Gibbs, Harry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
NPS MedicineWise
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698234/ https://www.ncbi.nlm.nih.gov/pubmed/31427842 http://dx.doi.org/10.18773/austprescr.2019.039 |
Ejemplares similares
-
Predicting the Risk of Recurrent Venous Thromboembolism: Current Challenges and Future Opportunities
por: Stevens, Hannah, et al.
Publicado: (2020) -
Venous anomalies and thromboembolism
por: Dix, Caroline, et al.
Publicado: (2023) -
Inherited Thrombophilias Are Associated with an Increased Risk of COVID-19 Associated Venous Thromboembolism: A Prospective Population-Based Cohort Study
por: Stevens, Hannah P, et al.
Publicado: (2021) -
Current Status of New Anticoagulants in the Management of Venous Thromboembolism
por: Montoya, Roberto C., et al.
Publicado: (2012) -
Management of Venous Thromboembolism in Children: Current Recommendations and Therapeutic Options
por: Bosch, Alessandra, et al.
Publicado: (2020)